The effect of glutamine infusion on the inflammatory response and HSP70 during human experimental endotoxaemia
Open Access
- 1 January 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 13 (1), R7
- https://doi.org/10.1186/cc7696
Abstract
Glutamine supplementation has beneficial effects on morbidity and mortality in critically ill patients, possibly in part through an attenuation of the proinflammatory cytokine response and a stimulation of heat shock protein (HSP)70. We infused either alanine-glutamine or saline during endotoxin challenge and measured plasma cytokines and HSP70 protein expression.This publication has 31 references indexed in Scilit:
- Variation in basal heat shock protein 70 is correlated to core temperature in human subjectsAmino Acids, 2008
- Exogenous glutamine: The clinical evidenceCritical Care Medicine, 2007
- Exogenous glutamine—Compensating a shortage?Critical Care Medicine, 2007
- L-alanyl-L-glutamine dipeptide–supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study*Critical Care Medicine, 2006
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Parenteral l-alanyl-l-glutamine improves 6-month outcome in critically ill patients*Critical Care Medicine, 2002
- Glutamine supplementation in serious illness: A systematic review of the evidence*Critical Care Medicine, 2002
- A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutritionGut, 1999
- A descriptive study of skeletal muscle metabolism in critically ill patientsCritical Care Medicine, 1996
- Metabolic disorders in severe abdominal sepsis: Glutamine deficiency in skeletal muscleClinical Nutrition, 1982